Droperidol

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Administration

Adult Dosing

Combative patient

  • 5-10mg IV
  • 10mg IM

Headache

  • 2.5mg IV or 2.5-5mg IM

Nausea/vomiting

  • 0.625-2.5mg IV

Pediatric Dosing

Nausea/vomiting

  • 2-12yo: 0.015-0.1mg/kg IV/IM

Special Populations

  • Pregnancy Rating: C
  • Lactation risk: Infant risk cannot be ruled out
  • Renal dosing: Administer with caution
  • Hepatic dosing: Administer with caution

Contraindications

  • Allergy to class/drug
  • Known or suspected prolonged QT

Adverse Reactions

Serious

  • Prolonged QT, torsades, ventricular tachycardia, cardiac arrest
    • Note: effect on QT interval is dose-dependent
  • Neuroleptic malignant syndrome
  • Anaphylaxis

Common

  • Somnolence, dysphoria
  • Anxiety, restlessness, hyperactivity
  • Hypotension
  • Tachycardia

Pharmacology

  • Half-life: 123-147m (adults), 75-127m (children)
  • Metabolism: hepatic
  • Excretion: mostly renal

Mechanism of Action

  • Dopamine (D2) antagonist. Some serotonergic, histaminergic, and α-adrenergic effect

Comments

See Also

References